Heart pump support for high-risk heart procedures
Part of Heart & circulation clinical trials.
This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 90 years old.
- Your heart pumps out 35% or less of its blood (low ejection fraction).
- You have serious blockages in your heart arteries, such as in the main left artery, all three major arteries, a graft, or heavily calcified vessels.
- Your doctor says you need a stent but bypass surgery is too risky or you don't want it.
- You do not have recent shock, heart attack, stroke, or bleeding issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a tiny heart pump to support blood flow during a procedure to open blocked arteries in people with very weak hearts (less than 35% pumping strength). It aims to see if this pump makes the procedure safer and more effective.
This study tracks patients with weakened heart function who undergo complex stent procedures (PCI) instead of open-heart surgery. Researchers will follow your progress to understand how well these procedures work in patients who are too sick for traditional bypass surgery.
This trial tests a device called Ventiflow LP that supports the heart during high-risk stent placement (PCI) in people whose hearts are weak or have complex blockages. It may be an option if surgery is too risky or you prefer not to have it.
This trial tests a new device called the VentriCure that helps the heart pump blood. It is for people with severe coronary artery disease and a weak heart who cannot have bypass surgery or choose not to.
This trial is testing a temporary heart pump device that helps your heart pump blood when it's too weak to do its job. It's for people who have severe heart failure (cardiogenic shock) despite getting powerful medications to keep their heart working.
This trial is testing whether using a special heart pump (PulseCath iVAC2L) during complex, high-risk angioplasty can help people with very weak hearts. It's for people who need a procedure for complicated coronary artery blockages.
Hear when a new High-Risk Percutaneous Coronary Intervention (High-risk PCI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.